{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:09:25Z","timestamp":1785251365196,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The incidence of BM among Canadian cancer patients is unknown. We aimed to estimate IP of BM at the time of cancer diagnosis and during the lifetime of patients with selected primary cancers. Data on BM at diagnosis from 2010\u20132017 was obtained from the CCR. Site-specific IPs of BM were estimated from provincial registries containing \u226590% complete data on BM. The CCR IP estimates and the IP estimates from literature were applied to the total diagnosed primary cancers to estimate the number of concurrent BM and lifetime BM from 2010\u20132017 in Canada, respectively. The annual average number of patients with BM at diagnosis from all cancer sites was approximately 3227. The site-specific IPs of BM at diagnosis were: lung (9.42%; 95% CI: 9.16\u20139.68%), esophageal (1.58%; 95% CI: 1.15\u20132.02%), kidney\/renal pelvis (1.33%; 95% CI: 1.12\u20131.54%), skin melanoma (0.73%; 95% CI: 0.61\u20130.84%), colorectal (0.22%; 95% CI: 0.18\u20130.26%), and breast (0.21%; 95% CI: 0.17\u20130.24%). Approximately 76,546 lifetime BM cases (or 5.70% of selected fifteen primary cancers sites) were estimated to have occurred from the 2010\u20132017 cancer patient cohort. These findings reflect results of population analyses in the US and Denmark. We recommend improved standardization of the collection of BM data within the CCR.<\/jats:p>","DOI":"10.3390\/curroncol29030169","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:26:22Z","timestamp":1647811582000},"page":"2091-2105","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Brain Metastases among Cancer Patients Diagnosed from 2010\u20132017 in Canada: Incidence Proportion at Diagnosis and Estimated Lifetime Incidence"],"prefix":"10.3390","volume":"29","author":[{"given":"Jiaqi L.","family":"Liu","sequence":"first","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-2255","authenticated-orcid":false,"given":"Emily V.","family":"Walker","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-4359","authenticated-orcid":false,"given":"Yuba Raj","family":"Paudel","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith G.","family":"Davis","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-9924","authenticated-orcid":false,"given":"Yan","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/now197","article-title":"Systemic Therapy of Brain Metastases: Non\u2013Small Cell Lung Cancer, Breast Cancer, and Melanoma","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1188\/15.CJON.475-478","article-title":"Current Perspectives in the Management of Brain Metastases","volume":"19","author":"Saria","year":"2015","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nec.2010.08.007","article-title":"Epidemiology of Metastatic Brain Tumors","volume":"22","author":"Fox","year":"2011","journal-title":"Neurosurg. Clin. North Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/neuonc\/nos152","article-title":"Toward Determining the Lifetime Occurrence of Metastatic Brain Tumors Estimated from 2007 United States Cancer Incidence Data","volume":"14","author":"Davis","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Sloan","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.bjc.6605373","article-title":"Brain Metastases Admissions in Sweden between 1987 and 2006","volume":"101","author":"Smedby","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/neuonc\/nou099","article-title":"Incidence of Brain Metastasis at Initial Presentation of Lung Cancer","volume":"17","author":"Villano","year":"2015","journal-title":"Neuro-oncology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"vdaa178","DOI":"10.1093\/noajnl\/vdaa178","article-title":"Incidence and Real-World Burden of Brain Metastases from Solid Tumors and Hematologic Malignancies in Ontario: A Population-Based Study","volume":"3","author":"Habbous","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11060-017-2516-7","article-title":"Estimating the Annual Frequency of Synchronous Brain Metastasis in the United States 2010\u20132013: A Population-Based Study","volume":"134","author":"Kromer","year":"2017","journal-title":"J. Neurooncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e000024","DOI":"10.1136\/esmoopen-2015-000024","article-title":"Descriptive Statistical Analysis of a Real Life Cohort of 2419 Patients with Brain Metastases of Solid Cancers","volume":"1","author":"Berghoff","year":"2016","journal-title":"ESMO Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and Treatment of Brain Metastases from Solid Tumors: Guidelines from the European Association of Neuro-Oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.nrl.0000106922.83090.71","article-title":"Brain Metastases","volume":"10","author":"Klos","year":"2004","journal-title":"Neurologist"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","article-title":"Brain Metastasis: Unique Challenges and Open Opportunities","volume":"1867","author":"Lowery","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Rev. Cancer"},{"key":"ref_14","unstructured":"Government of Canada, S.C. (2022, February 01). Canadian Cancer Registry (CCR), Available online: https:\/\/www23.statcan.gc.ca\/imdb\/p2SV.pl?Function=getSurvey&SDDS=3207."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/cncr.30000","article-title":"Risk of Brain Metastases in Patients with Nonmetastatic Lung Cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) Data","volume":"122","author":"Goncalves","year":"2016","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-012-2243-x","article-title":"Brain Metastases after Breast-Conserving Therapy and Systemic Therapy: Incidence and Characteristics by Biologic Subtype","volume":"136","author":"Arvold","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","unstructured":"(2022, March 16). Canadian Cancer Statistics 2018; Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada. Available online: https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/180612\/dq180612e-eng.htm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of Brain Metastases in a Cohort of Patients with Carcinoma of the Breast, Colon, Kidney, and Lung and Melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"(2022, March 16). Canadian Cancer Statistics 2021; Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/health-promotion-chronic-disease-prevention-canada-research-policy-practice\/vol-41-no-11-2021\/canadian-cancer-statistics-2021.html.","DOI":"10.24095\/hpcdp.41.11.09"},{"key":"ref_20","first-page":"21","article-title":"Cancer in Canada: Stage at Diagnosis","volume":"29","author":"Bryan","year":"2018","journal-title":"Health Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and Prognosis of Patients with Brain Metastases at Diagnosis of Systemic Malignancy: A Population-Based Study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref_22","first-page":"4655","article-title":"Recent Trends in Epidemiology of Brain Metastases: An Overview","volume":"32","author":"Tabouret","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/bjc.2012.163","article-title":"Incidence and Time Trends of Brain Metastases Admissions among Breast Cancer Patients in Sweden","volume":"106","author":"Frisk","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS Metastases in Breast Cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 Expression in Triple-Negative Breast Cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1756286418785502","DOI":"10.1177\/1756286418785502","article-title":"New Developments in Brain Metastases","volume":"11","author":"Berghoff","year":"2018","journal-title":"Ther. Adv. Neurol. Disord"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00432-018-2697-2","article-title":"Molecular Subtype Predicts Incidence and Prognosis of Brain Metastasis from Breast Cancer in SEER Database","volume":"144","author":"Kim","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/01.pas.0000213306.05811.b9","article-title":"Breast Cancers with Brain Metastases Are More Likely to Be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5\/6, and Overexpress HER2 or EGFR","volume":"30","author":"Hicks","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.3747\/co.23.3161","article-title":"Burden of Illness for Metastatic Melanoma in Canada, 2011-2013","volume":"23","author":"Ernst","year":"2016","journal-title":"Curr. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF Gene in Human Cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/CMR.0000000000000338","article-title":"Does the Distribution Pattern of Brain Metastases during BRAF Inhibitor Therapy Reflect Phenotype Switching?","volume":"27","author":"Haueis","year":"2017","journal-title":"Melanoma Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000461576","article-title":"Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients","volume":"10","author":"Imafuku","year":"2017","journal-title":"Case Rep. Oncol."},{"key":"ref_33","first-page":"1546","article-title":"How to Differentiate Pseudoprogression from True Progression in Cancer Patients Treated with Immunotherapy","volume":"9","author":"Ma","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/neuonc\/noy195","article-title":"CBTR founding affiliates Malignant Primary Brain and Other Central Nervous System Tumors Diagnosed in Canada from 2009 to 2013","volume":"21","author":"Walker","year":"2019","journal-title":"Neuro-Oncology"},{"key":"ref_35","first-page":"3","article-title":"An Examination of the NAACCR Method of Assessing Completeness of Case Ascertainment Using the Canadian Cancer Registry","volume":"24","author":"Zakaria","year":"2013","journal-title":"Health Rep."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/3\/169\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:38:58Z","timestamp":1760135938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/3\/169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["curroncol29030169"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29030169","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}